ATTENTION Investors and Finance Professionals:

If you are reading this you should sign up for ValuEngine's award-winning stock
valuation and forecast service at the low price of $19.95/month!
NO OBLIGATION, Two-Week FREE TRIAL!
CLICK HERE

March 15, 2010

Cardiome Pharma

Drug Maker Garners Strong Short and Long-Term Forecast Figures.

Cardiome Pharma Corp., a life sciences company, focuses on developing drugs to

treat or prevent cardiovascular diseases. The company has been losing money, but posted a
small gain in Q4, 2009. The company is predicted to benefit from a close relationship with
giant pharma company Merck--the company develops cardiac drugs which are then
developed and commercialized by Merck.
ValuEngine has issued a BUY recommendation for CARDIOME PHARMA CORP
(CRME). Based on the information we have gathered and our resulting research, we feel that
CRME has the probability to OUTPERFORM average market performance for the next year.
The company exhibits ATTRACTIVE expected EPS growth, market valuation and
momentum. The ticker's short and long-term foreast figures are particularly strong when
compared to other companies in our universe right now.
Subscribers can check out the latest figures on CRM HERE.

Not a ValuEngine Premium Website member? Then please consider signing up for our
no obligation, two-week free trial today.

To Sign Up for a FREE TRIAL, Please Click the Logo Below

MARKET OVERVIEW
Summary of VE Stock Universe
Stocks Undervalued 47.31%
Stocks Overvalued 52.69%
Stocks Undervalued by 20% 23.34%
Stocks Overvalued by 20% 25.02%

SECTOR OVERVIEW

Last 12- P/E

Sector Change MTD YTD Valuation
MReturn Ratio
Basic Industries 0.50% 5.37% 4.65% 13.90% overvalued 117.35% 27.21
Capital Goods 0.13% 5.89% 8.48% 9.40% overvalued 93.45% 23.68
Consumer Durables 0.13% 4.94% 7.63% 16.27% overvalued 101.47% 23.27
Consumer Non-Durables 0.10% 4.17% 5.59% 4.81% overvalued 103.26% 18.83
Consumer Services 0.35% 6.21% 8.91% 6.46% overvalued 97.26% 23.25
Energy 1.24% 4.95% 2.66% 12.37% overvalued 106.01% 21.77
Finance 0.06% 3.98% 7.07% 2.20% overvalued 61.57% 19.18
Health Care -0.12% 4.28% 6.17% 2.98% undervalued 84.81% 20.91
Public Utilities -0.03% 3.40% -0.29% 1.67% overvalued 59.45% 16.48
Technology -0.09% 3.72% 6.07% 0.09% overvalued 93.42% 28.7
Transportation 0.21% 4.98% 7.19% 7.37% overvalued 96.70% 20.37